A detailed history of Legal & General Group PLC transactions in Surmodics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 2,572 shares of SRDX stock, worth $99,587. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,572
Previous 2,572 -0.0%
Holding current value
$99,587
Previous $99,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$38.47 - $42.24 $16,888 - $18,543
439 Added 20.58%
2,572 $99,000
Q2 2024

Aug 14, 2024

BUY
$25.39 - $42.1 $17,163 - $28,459
676 Added 46.4%
2,133 $89,000
Q1 2024

May 14, 2024

SELL
$27.44 - $35.56 $932 - $1,209
-34 Reduced 2.28%
1,457 $42,000
Q4 2023

Feb 15, 2024

SELL
$28.47 - $38.49 $1,309 - $1,770
-46 Reduced 2.99%
1,491 $54,000
Q3 2023

Nov 14, 2023

SELL
$28.28 - $38.36 $3,308 - $4,488
-117 Reduced 7.07%
1,537 $49,000
Q2 2023

Aug 14, 2023

SELL
$17.67 - $31.31 $44,316 - $78,525
-2,508 Reduced 60.26%
1,654 $51,000
Q1 2023

May 15, 2023

SELL
$17.13 - $38.52 $539,286 - $1.21 Million
-31,482 Reduced 88.32%
4,162 $94,000
Q4 2022

Feb 14, 2023

BUY
$29.44 - $37.31 $14,720 - $18,655
500 Added 1.42%
35,644 $1.22 Million
Q3 2022

Nov 14, 2022

BUY
$28.84 - $38.92 $15,256 - $20,588
529 Added 1.53%
35,144 $1.07 Million
Q2 2022

Aug 22, 2022

BUY
$33.25 - $45.11 $10,041 - $13,623
302 Added 0.88%
34,615 $1.29 Million
Q1 2022

May 16, 2022

SELL
$40.68 - $49.72 $11,634 - $14,219
-286 Reduced 0.83%
34,313 $1.56 Million
Q4 2021

Feb 14, 2022

BUY
$43.21 - $57.6 $45,889 - $61,171
1,062 Added 3.17%
34,599 $1.67 Million
Q3 2021

Nov 15, 2021

BUY
$52.8 - $60.32 $145,411 - $166,121
2,754 Added 8.95%
33,537 $1.86 Million
Q2 2021

Aug 12, 2021

SELL
$51.29 - $59.15 $458,070 - $528,268
-8,931 Reduced 22.49%
30,783 $1.67 Million
Q1 2021

May 17, 2021

BUY
$42.18 - $56.07 $31,255 - $41,547
741 Added 1.9%
39,714 $2.23 Million
Q4 2020

Feb 12, 2021

SELL
$35.18 - $43.52 $12,172 - $15,057
-346 Reduced 0.88%
38,973 $1.7 Million
Q3 2020

Nov 13, 2020

BUY
$37.98 - $48.72 $16,863 - $21,631
444 Added 1.14%
39,319 $1.53 Million
Q2 2020

Aug 14, 2020

BUY
$31.07 - $44.74 $88,332 - $127,195
2,843 Added 7.89%
38,875 $1.68 Million
Q1 2020

May 14, 2020

BUY
$22.46 - $42.24 $2,717 - $5,111
121 Added 0.34%
36,032 $1.2 Million
Q4 2019

Feb 13, 2020

BUY
$39.01 - $47.51 $100,723 - $122,670
2,582 Added 7.75%
35,911 $1.49 Million
Q3 2019

Nov 13, 2019

BUY
$38.66 - $47.41 $60,193 - $73,817
1,557 Added 4.9%
33,329 $1.52 Million
Q2 2019

Aug 14, 2019

SELL
$38.23 - $47.43 $3,478 - $4,316
-91 Reduced 0.29%
31,772 $1.29 Million
Q1 2019

May 15, 2019

BUY
$41.26 - $58.35 $138,468 - $195,822
3,356 Added 11.77%
31,863 $1.39 Million
Q4 2018

Feb 15, 2019

BUY
$44.93 - $73.38 $7,862 - $12,841
175 Added 0.62%
28,507 $1.35 Million
Q3 2018

Nov 20, 2018

BUY
$56.85 - $80.35 $113,302 - $160,137
1,993 Added 7.57%
28,332 $2.11 Million
Q2 2018

Aug 10, 2018

BUY
$35.85 - $57.05 $58,901 - $93,733
1,643 Added 6.65%
26,339 $1.45 Million
Q1 2018

May 17, 2018

BUY
$27.0 - $38.5 $22,734 - $32,417
842 Added 3.53%
24,696 $941,000
Q4 2017

Feb 13, 2018

BUY
$28.0 - $33.2 $667,912 - $791,952
23,854
23,854 $669,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $542M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.